| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5943926 | Atherosclerosis | 2015 | 7 Pages |
Abstract
The findings of this study demonstrates that in stable atherosclerosis, 12 weeks of treatment with BMS-582949 did not reduce arterial inflammation or hs-CRP compared to placebo, whereas intensification of statin therapy significantly decreased arterial inflammation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hamed Emami, Esad Vucic, Sharath Subramanian, Amr Abdelbaky, Zahi A. Fayad, Shuyan Du, Eli Roth, Christie M. Ballantyne, Emile R. Mohler, Michael E. Farkouh, Joonyoung Kim, Matthew Farmer, Li Li, Alexander Ehlgen, Thomas H. Langenickel, Linda Velasquez,